Streetbeat News

Stock Prices

MBCN

Middlefield Banc Corp. (NASDAQ:MBCN) has appointed Ronald L. Zimmerly, Jr. as its new CEO, effective January 1, 2024. He will succeed James R. Heslop, II, who is retiring. Zimmerly is currently the President and Director of Middlefield and The Middlefield Banking Company. Heslop will also resign from the Board of Directors on December 31, 2023, and the Board will be reduced from 13 to 12 members.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:00 pm

AKRO

11 Wall Street analysts have recently provided their opinions on Akero Therapeutics (NASDAQ:AKRO), with an average price target of $52.27, which is significantly higher than the current price of $13.95. The consensus among these analysts is positive, with 4 bullish and 7 somewhat bullish ratings. However, this target represents an 18.15% decrease from the previous target of $63.86. Analysts' ratings are based on comprehensive analysis, including company data and industry trends.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:00 pm

AYX

Alteryx (NYSE:AYX) has received 8 analyst ratings in the last quarter with an average price target of $45.0, representing an upside from the current price of $37.3. The ratings include 4 bullish, 1 somewhat bullish, 1 indifferent, and 2 somewhat bearish. Over the past month, the average price target has increased by 38.46%. Analysts typically review stocks quarterly or after major company updates, basing their ratings on financial predictions and company performance.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:00 pm

ALLK

Barclays analyst Carter Gould has maintained an Underweight rating on Allakos (NASDAQ:ALLK) and reduced the price target from $2.5 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:59 pm

BUD

RLX

USFD

Three consumer staples stocks, US Foods Holding Corp. (USFD), Anheuser-Busch InBev SA/NV (BUD), and RLX Technology Inc. (RLX), are showing overbought signals with RSI values above 70. USFD reported strong Q3 sales and market share gains, BUD reported a 5% sales growth but missed estimates, and RLX posted upbeat Q3 earnings. All three stocks saw slight increases in their share prices on Monday.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 12:58 pm

TLIS

Trading in shares of Talis Biomedical (TLIS) has been halted pending the release of news. The halt is due to a pending news announcement, which has not yet been disclosed to the public. Investors are awaiting further details to understand the implications of the news on the company's operations and stock price.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:55 pm

MGIC

Magic Software (NASDAQ:MGIC) reported Q3 earnings with an EPS of $0.21, missing estimates by 19.23% compared to the expected $0.26. Revenue also declined by $14.48 million from the same period last year. In the previous quarter, the company had exceeded EPS estimates but experienced a 2.91% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:55 pm

ACM

AECOM (NYSE:ACM) reported a 12% Y/Y revenue increase in Q4 FY23 to $3.84 billion, surpassing estimates. Adjusted EPS of $1.01 beat consensus, and the company raised its share buyback authorization to $1 billion and increased its quarterly dividend by 22%. AECOM's FY24 outlook anticipates adjusted EPS of $4.35-$4.55 and adjusted EBITDA of $1.065-$1.105 billion. Shares rose 1.65% in premarket trading.

Portfolio Pulse from Lekha Gupta

November 14, 2023 | 12:54 pm

MGIC

Magic Software forecasts Q4 revenue to be between $115M-$125M, which falls short of the estimated $133.65M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:53 pm

MGIC

Magic Software (NASDAQ:MGIC) reported Q3 adjusted EPS of $0.21, missing the $0.27 estimate, and sales of $129.48M, below the $146.40M estimate. This reflects a 25% decrease in earnings and a 10.06% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:49 pm